• Abstract ScoreCard
support

Technical Support


Hours: 9 – 9 ET, Mon - Fri

Phone: (Direct) (410) 638-9239

Phone: (Toll Free) (877) 426-6323

Email: Help@ConferenceAbstracts.com

Web: www.ConferenceAbstracts.com

close this panel

Event Details

Name: JADPRO Live 2018

Location: Diplomat Hotel, Hollywood, Florida

Date: November 1–4, 2018

Website: Click here

Organizers

Abstract Submissions: Kelley Moore, RN (kmoore@hbside.com); Phone: (901) 603-7376

close this panel
Welcome to Abstract Submissions

JADPRO Live 2018
Abstract Submission Guidelines

Thank you for your interest in abstract submissions for the sixth annual JADPRO Live CE-accredited conference. The event audience will include nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists and physicians. The conference chair invites our oncology advanced practitioner attendees who are members of the Advanced Practitioner Society for Hematology and Oncology (APSHO) to submit abstracts to be considered for moderated poster presentations at the conference.

The abstract submission deadline is 11:59pm PDT on August 1, 2018.

Abstracts may be submitted by oncology advanced practitioners who are members of APSHO and plan to attend the live conference. Abstract submitters must complete all submission requirements by 11:59pm PDT on August 1, 2018 for the abstract to enter the review process and be considered for poster presentations. The abstract deadline will not be extended. There will be no additional deadlines for late-breaking data.

Information Required for Abstract Submission
An abstract submission must include the following information by the deadline to enter the review process: Submitters are encouraged to ask questions during the process by contacting the abstract coordinator, Kelley Moore, kmoore@hbside.com. Likewise, if there are questions regarding the information submitted for an abstract, the submitting author will be notified. Providing references during the submission process is not required; however, submitters will have an opportunity to upload references regarded essential for review, as well as necessary permissions. Early completion of submissions is encouraged. Once the deadline has passed, changes to the abstract submission are not permitted.

Abstract Topics and Categories
The APSHO member should submit an abstract that describes a completed initiative, the significance of the results/outcomes or conclusions, and includes implications for advanced practitioners in oncology. See more information below regarding complete and incomplete initiatives. Topics can include research, clinical/evidence-based practice, educational initiatives, leadership, professional development and advanced practice projects. Abstracts should be no more than 500 words and organized with paragraph headings. The word count does not include the title, but does include paragraph headings.

Example paragraph headings: Abstract submitters will be required to designate a category for the abstract submission: It is advised that authors address within the abstract the significance and purpose for oncology advanced practice with a clear description of the role of, and implications for, the advanced practitioner. Abstracts should describe completed work; however, projects in progress may be considered for review if the content provided is compelling and pertinent to the advanced practitioner prior to completion; please contact the abstract coordinator to discuss. A maximum of 10 authors will be allowed for each abstract. Abstract submitters may be contacted for clarity regarding co-author information, role or contributions. Once the deadline has passed, changes to the abstract submission are not permitted. Late-breaking data past the submission deadline may be included in the poster should the abstract be accepted. Requirements must be met and approved for an abstract to move into the review process. Abstracts may not be written or submitted by parties on behalf of authors. Submissions of this type will be declined.

APSHO Membership Information
Members who plan to submit abstracts must be current on membership dues, have completed member profiles, and be members in good standing. For more information regarding your current membership status or to join APSHO, please visit www.apsho.org.

Review Process
All completed abstract submissions that meet requirements will undergo review, including review by two or more peer reviewers in a double-blind review process via the electronic submission system. (Authors and reviewers will remain unknown to each other). The submitting author may contact the abstract coordinator for questions throughout the process. The abstract coordinator may contact submitting authors with questions regarding abstract submissions.

The abstract peer review will be focused on the following criteria, across 6 categories. Reviewers will be asked to respond to abstracts utilizing a 7-point scale, with 1 being strongly disagree and 7 being strongly agree. The 6 categories and their elements are as follows:

Category 1: Objective (Context, Setting, Aim, Goal, Purpose)
  1. The topic is significant, novel and central to oncology advanced practice.
  2. The background/significance of the issue or topic is well-summarized and directed to the AP.
  3. The purpose of the educational project, clinical project/issue, leadership or professional activity or research is clearly defined for oncology advanced practice.
  4. The role of the oncology advanced practitioner is distinctly described.
Category 2: Methods (Design, Intervention, Approaches, Procedures, Processes)
  1. How the purpose/objective was addressed is included.
  2. The implementation methods, interventions, approaches, procedures, and/or processes are described.
Category 3: Results (Findings, Outcome measures, Effects, Discoveries)
  1. The goals are evaluated according to specific measures.
  2. The outcomes are applicable to and valuable for oncology advanced practitioners.
Category 4: Conclusions (Interpretation, Summary, Evaluation)
  1. The outcomes and findings are clearly summarized and discussed.
  2. The implications for oncology advanced practice are clearly identified.
Category 5: Recommendations (Implications, Proposals, Applications)
  1. Suggestions, recommendations and/or next steps are included and applicable to advanced practice.
Category 6: Innovation
  1. The research, clinical/evidence-based practice project, advanced practice initiative/activity is innovative and progressive.
Peer reviewers will also be asked to provide a recommendation for the abstract outcome. Review chairs will make final decisions. All correspondence will be directed to the submitting author, including notification of review outcomes. Only accepted abstracts will be eligible for poster presentation at the conference.

Poster Presentation Requirements
Submitting authors whose abstracts are accepted for poster presentation will be contacted by the abstract coordinator, who will provide additional details and outline next steps in the process, including poster number, specifications for poster development, author tasks, presentation times and any additional requirements for final approval. Poster presentations of accepted abstracts are open to APSHO member submitting authors who are registered and paid conference participants. It is anticipated that the submitting author and presenting author are one and the same. In the event an author other than the submitting author must present, or if there are any questions regarding the role of the presenting author, please contact the abstract organizer. An APSHO member author listed as a co-author on the abstract at the time of submission will be considered to present under extenuating circumstances with approval prior to the conference.

The Presenting Author will complete the following tasks in the submission platform: Poster tasks will have specific deadlines. All communication regarding poster presentation will be directly with the submitting/presenting author. If there is a problem anticipated regarding meeting deadlines, the abstract coordinator should be notified. All posters should be displayed before 7pm EDT on Thursday, November 1, 2018 at the Diplomat Hotel in Hollywood, Florida (conference venue). Please note this date for arranging travel to the conference and contact the abstract coordinator for any questions or concerns.

Poster presentations for accepted abstracts will be held on Friday November 2 and Saturday November 3, 2018 at designated times. The submitting/presenting author should be on site to discuss the poster for the duration of both designated poster sessions during the conference. If extenuating circumstances arise that will prevent the submitting author from presenting, the abstract coordinator must be notified before the first poster session.

Accepted abstracts, posters, and presenting author information will be available in the conference app during the conference as well as on the JADPRO Live official conference website, www.jadprolive.com. Accepted abstracts will be published in an issue of the Journal of the Advanced Practitioner in Oncology (JADPRO) following the live conference. Publication of the abstract will not jeopardize future submission of a manuscript; authors are encouraged to continue work to manuscript submission.

Outstanding Poster Award
The second annual Outstanding Poster Award will take place at JADPRO Live 2018 in Hollywood, Florida, and will be granted on-site. To be eligible for the award, the final pdf of the poster for the accepted abstract must be uploaded to the electronic submission system by 5pm EDT on Thursday, October 18, 2018. All posters submitted by this time will be taken through a review process by the Poster Award Review Committee and considered for the award.

Just as with abstract review, the posters will be evaluated on the following criteria, across 6 categories. The committee will be asked to respond to posters utilizing a 7-point scale, with 1 being strongly disagree and 7 being strongly agree. The 6 categories and their elements are as follows:

Category 1: Objective (Context, Setting, Aim, Goal, Purpose)
  1. The topic is significant, novel and central to oncology advanced practice.
  2. The background/significance of the issue or topic is well-summarized and directed to the AP.
  3. The purpose of the educational project, clinical project/issue, leadership or professional activity or research is clearly defined for oncology advanced practice.
  4. The role of the oncology advanced practitioner is distinctly described.
Category 2: Methods (Design, Intervention, Approaches, Procedures, Processes)
  1. How the purpose/objective was addressed is included.
  2. The implementation methods, interventions, approaches, procedures, and/or processes are described.
Category 3: Results (Findings, Outcome measures, Effects, Discoveries)
  1. The goals are evaluated according to specific measures.
  2. The outcomes are applicable to and valuable for oncology advanced practitioners.
Category 4: Conclusions (Interpretation, Summary, Evaluation)
  1. The outcomes and findings are clearly summarized and discussed.
  2. The implications for oncology advanced practice are clearly identified.
Category 5: Recommendations (Implications, Proposals, Applications)
  1. Suggestions, recommendations and/or next steps are included and applicable to advanced practice.
Category 6: Innovation
  1. The research, clinical/evidence-based practice project, advanced practice initiative/activity is innovative and progressive.
Once evaluated, the committee will indicate overall impressions for each poster and will select the Outstanding Poster Award winner. The poster award winner will receive an Outstanding Poster Award ribbon, Outstanding Poster Award name badge flags for all attending poster authors, special announcement and recognition at JADPRO Live 2018, recognition in the meeting coverage issue of the Journal of the Advanced Practitioner in Oncology (JADPRO) following the conference, and recognition in the Advanced Practitioner Society for Hematology and Oncology (APSHO) member newsletter.

Accessing the Submission System
Submitting authors may access the Abstract Submission system below. After reading the guidelines and gathering information for a submission, the submitting author should click on “Create Account” under the New Users area to create an account for the submission system. Once an account is created, the system will provide the user with an access key, allowing the submitting author to access the abstract up until the submission deadline. Submissions that are incomplete at the time of the deadline will no longer be able to be accessed.

For questions or concerns about abstracts and posters for JADPRO Live 2018, please contact Kelley Moore at kmoore@hbside.com.

Log in to the Abstract ScoreCard

New Users

Click 'Create Account' to begin your first submission.

Create Account

Already a User?

Log in to the Abstract ScoreCard

Lost your access key? or Need help?

Questions? Organizer: Kelley Moore, RN - kmoore@hbside.com / (901) 603-7376